{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T04:17:59Z","timestamp":1742962679848,"version":"3.40.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,25]]},"DOI":"10.7759\/cureus.81160","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T18:44:48Z","timestamp":1742928288000},"source":"Crossref","is-referenced-by-count":0,"title":["Left Atrial Appendage Thrombus in Low CHA2DS2VASc Score in Persistent Atrial Fibrillation"],"prefix":"10.7759","author":[{"given":"Ezelea Elwina","family":"Walter Sandosam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd Khairi","family":"Othman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishinan","family":"Saravanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zurkurnai","family":"Yusof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W Yus Haniff","family":"W Isa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/976976","article-title":"Comparison of atrial fibrillation in the young versus that in the elderly: a review","volume":"2013","author":"Sankaranarayanan R","year":"2013","unstructured":"Sankaranarayanan R, Kirkwood G, Dibb K, Garratt CJ. Comparison of atrial fibrillation in the young versus that in the elderly: a review. Cardiol Res Pract. 2013, 2013:976976. 10.1155\/2013\/976976","journal-title":"Cardiol Res Pract"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.01.044","article-title":"Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score","author":"Lip GY","year":"2015","unstructured":"Lip GY, Skj\u00f8th F, Rasmussen LH, Larsen TB. Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score. 2015. 10.1016\/j.jacc.2015.01.044"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.15420\/aer.2022.08","article-title":"Association between left atrial appendage morphology and function and the risk of ischaemic stroke in patients with atrial fibrillation","volume":"11","author":"Dudzi\u00f1ska-Szczerba K","year":"2022","unstructured":"Dudzi\u00f1ska-Szczerba K, Ku\u0142akowski P, Micha\u0142owska I, Baran J. Association between left atrial appendage morphology and function and the risk of ischaemic stroke in patients with atrial fibrillation. Arrhythm Electrophysiol Rev. 2022, 11:e09. 10.15420\/aer.2022.08","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2019-314898","article-title":"Stroke and thromboembolism prevention in atrial fibrillation","volume":"106","author":"Jame S","year":"2020","unstructured":"Jame S, Barnes G. Stroke and thromboembolism prevention in atrial fibrillation. Heart. 2020, 106:10-7. 10.1136\/heartjnl-2019-314898","journal-title":"Heart"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd9100351","article-title":"Left atrial appendage thrombosis and oral anticoagulants: a meta-analysis of risk and treatment response","volume":"9","author":"Cheng YY","year":"2022","unstructured":"Cheng YY, Tan S, Hong CT, Yang CC, Chan L. Left atrial appendage thrombosis and oral anticoagulants: a meta-analysis of risk and treatment response. J Cardiovasc Dev Dis. 2022, 9:10.3390\/jcdd9100351","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2017.02.016","article-title":"Comparison of morphologic features and flow velocity of the left atrial appendage among patients with atrial fibrillation alone, transient ischemic attack, and cardioembolic stroke","volume":"119","author":"Lee Y","year":"2017","unstructured":"Lee Y, Park HC, Lee Y, Kim SG. Comparison of morphologic features and flow velocity of the left atrial appendage among patients with atrial fibrillation alone, transient ischemic attack, and cardioembolic stroke. Am J Cardiol. 2017, 119:1596-604. 10.1016\/j.amjcard.2017.02.016","journal-title":"Am J Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-018-0889-y","article-title":"Predictive value of left atrial appendage lobes on left atrial thrombus or spontaneous echo contrast in patients with non-valvular atrial fibrillation","volume":"18","author":"Wang F","year":"2018","unstructured":"Wang F, Zhu M, Wang X, et al.. Predictive value of left atrial appendage lobes on left atrial thrombus or spontaneous echo contrast in patients with non-valvular atrial fibrillation. BMC Cardiovasc Disord. 2018, 18:153. 10.1186\/s12872-018-0889-y","journal-title":"BMC Cardiovasc Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.15420\/aer.2021.51","article-title":"Atrial fibrosis, ischaemic stroke and atrial fibrillation","volume":"10","author":"Mahnkopf C","year":"2021","unstructured":"Mahnkopf C, Kwon Y, Akoum N. Atrial fibrosis, ischaemic stroke and atrial fibrillation. Arrhythm Electrophysiol Rev. 2021, 10:225-9. 10.15420\/aer.2021.51","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2010.01854.x","article-title":"Left atrial appendage dimensions predict the risk of stroke\/TIA in patients with atrial fibrillation","volume":"22","author":"Beinart R","year":"2011","unstructured":"Beinart R, Heist EK, Newell JB, Holmvang G, Ruskin JN, Mansour M. Left atrial appendage dimensions predict the risk of stroke\/TIA in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2011, 22:10-5. 10.1111\/j.1540-8167.2010.01854.x","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0894-7317(99)70105-7","article-title":"Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study)","volume":"12","author":"Goldman ME","year":"1999","unstructured":"Goldman ME, Pearce LA, Hart RG, Zabalgoitia M, Asinger RW, Safford R, Halperin JL. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). J Am Soc Echocardiogr. 1999, 12:1080-7. 10.1016\/s0894-7317(99)70105-7","journal-title":"J Am Soc Echocardiogr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2013.05.062","article-title":"Usefulness of left atrial appendage volume as a predictor of embolic stroke in patients with atrial fibrillation","volume":"112","author":"Burrell LD","year":"2013","unstructured":"Burrell LD, Horne BD, Anderson JL, Muhlestein JB, Whisenant BK. Usefulness of left atrial appendage volume as a predictor of embolic stroke in patients with atrial fibrillation. Am J Cardiol. 2013, 112:1148-52. 10.1016\/j.amjcard.2013.05.062","journal-title":"Am J Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.1032736","article-title":"Finding low CHA2DS2-VASc scores unreliable? Why not give morphological and hemodynamic methods a try?","volume":"9","author":"Sun Y","year":"2022","unstructured":"Sun Y, Ling Y, Chen Z, Wang Z, Li T, Tong Q, Qian Y. Finding low CHA2DS2-VASc scores unreliable? Why not give morphological and hemodynamic methods a try?. Front Cardiovasc Med. 2022, 9:1032736. 10.3389\/fcvm.2022.1032736","journal-title":"Front Cardiovasc Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.10.052","article-title":"Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1","volume":"65","author":"Friberg L","year":"2015","unstructured":"Friberg L, Skeppholm M, Ter\u00e9nt A. Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1. J Am Coll Cardiol. 2015, 65:225-32. 10.1016\/j.jacc.2014.10.052","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(15)60357-6","article-title":"Direct acting oral anticoagulants are more effective than vitamin- K-antagonists for the resolution of established left atrial thrombi in patients with atrial fibrillation","volume":"65","author":"Hammerstingl C","year":"2015","unstructured":"Hammerstingl C, Lambers M, Schueler R, Nickenig G. Direct acting oral anticoagulants are more effective than vitamin- K-antagonists for the resolution of established left atrial thrombi in patients with atrial fibrillation. JACC. 2015, 65:A357. 10.1016\/S0735-1097(15)60357-6","journal-title":"JACC"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1305485","article-title":"Catheter ablation in patients with atrial fibrillation and dilated cardiomyopathy","volume":"11","author":"Siow YK","year":"2024","unstructured":"Siow YK, Lin CY, Chung FP, et al.. Catheter ablation in patients with atrial fibrillation and dilated cardiomyopathy. Front Cardiovasc Med. 2024, 11:1305485. 10.3389\/fcvm.2024.1305485","journal-title":"Front Cardiovasc Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjco.2022.02.001","article-title":"Rhythm-monitoring strategy and arrhythmia recurrence in atrial fibrillation ablation trials: a systematic review","volume":"4","author":"Unni RR","year":"2022","unstructured":"Unni RR, Prager RT, Odabashian R, et al.. Rhythm-monitoring strategy and arrhythmia recurrence in atrial fibrillation ablation trials: a systematic review. CJC Open. 2022, 4:488-96. 10.1016\/j.cjco.2022.02.001","journal-title":"CJC Open"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euac194","article-title":"Rhythm monitoring, success definition, recurrence, and anticoagulation after atrial fibrillation ablation: results from an EHRA survey","volume":"25","author":"Schwab AC","year":"2023","unstructured":"Schwab AC, Anic A, Farkowski MM, et al.. Rhythm monitoring, success definition, recurrence, and anticoagulation after atrial fibrillation ablation: results from an EHRA survey. Europace. 2023, 25:676-81. 10.1093\/europace\/euac194","journal-title":"Europace"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/349170-left-atrial-appendage-thrombus-in-low-cha2ds2vasc-score-in-persistent-atrial-fibrillation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T18:44:50Z","timestamp":1742928290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/349170-left-atrial-appendage-thrombus-in-low-cha2ds2vasc-score-in-persistent-atrial-fibrillation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.81160","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,25]]}}}